Elimination of brush border membrane protein in urine caused by toxic alterations of the tubular cell.
D000293:Adolescent; D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000626:Aminopeptidases / Q000652:urine*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018826:CD13 Antigens; D002439:Cefotaxime; D002462:Cell Membrane / Q000201:enzymology*; D002511:Cephalosporins / Q000627:therapeutic use; D002945:Cisplatin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007687:Kidney Tubules, Proximal / Q000187:drug effects / Q000201:enzymology* / Q000503:physiopathology; D007700:Kinetics; D008297:Male; D008565:Membrane Proteins / Q000652:urine*; D008871:Microvilli / Q000187:drug effects / Q000201:enzymology*; D008875:Middle Aged; D009428:Netilmicin / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008565:Membrane Proteins; D013453:Sulfonylurea Compounds; D009428:Netilmicin; D000583:Amikacin; D000626:Aminopeptidases; D018826:CD13 Antigens; D002439:Cefotaxime; D002945:Cisplatin